Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA appoints Isabel De Paoli as communications head

She will replace Walter Huber, who retires inMarch 2016

Merck KGaA Isabel De PaoliMerck KGaA has picked a new head of group communications to take over from Walter Huber, who is set to retire next March after 18 years in the role.

Isabel De Paoli (pictured) is currently head of group strategy at the German life sciences, health and materials company and will officially step into her new role when Huber's tenure ends.

Until then she will spend her time preparing for her new role and Heiko Schön has taken over from her as head of group strategy at Merck.

In her new role, De Paoli will be responsible for all global communications at Merck.

Karl-Ludwig Kley, chairman of Merck's executive board, said: “Isabel De Paoli brings many years of experience in shaping and implementing strategic topics as well as an international background - capabilities that are becoming ever more important in a rapidly changing communications environment.”

De Paoli joined Merck in August 2006 as business development manager, chemicals, was appointed head of strategic planning oncology in 2009 and in 2012 took on responsibility for group strategy.

Prior to joining Merck she began her career as a consultant, working for The Boston Consulting Group and then moving to private equity firm Permira.

11th August 2015

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...